Veeva Q2 FY27: Net income +36.5% to $273.4M on 17.6% revenue growth; $472.7M buyback

Filed August 27, 2026 · Period ending July 31, 2026 · Compared to 10-Q Aug 29, 2025 · ~1 min read

Key Changes

• high

  Net income rose 36.5% to $273.4M (diluted EPS $1.66, +39.5%) on 17.6% revenue growth to $928.0M, driven by subscription +16% and professional services +24%. Operating income climbed 40% to $275.0M as the OBBBA tax benefit lowered the effective rate to 21.8% from 24.5%.

  MD&A: Results of Operations verify on EDGAR →
• high

  Veeva CRM support window shortened nine months to Dec 31, 2029 (from Sep 1, 2030), accelerating migration pressure. Multiple customers have informed Veeva of intent to move to Salesforce CRM, beyond prior public Salesforce announcements.

  Risk Factors: CRM Migration verify on EDGAR →
• medium

  Acquired Ostro (AI-driven patient/doctor chat platform) for $90M ($70M net of cash) in March 2026, adding $44.4M goodwill and $25.5M intangibles. Veeva AI now positions "agentic AI" and "agents" as distinct product categories alongside applications and data.

  Notes: Business Combinations & Product Taxonomy view on EDGAR →